Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Systemic Sclerosis
Related studies linked through entity extraction aliases.
Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)
- Status
- TERMINATED
- Phase
- PHASE1
Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis
- Status
- TERMINATED
- Phase
- PHASE2
Pulmonary Arterial Hypertension in Systemic Sclerosis
- Status
- UNKNOWN
- Phase
- N/A
Low-Dose Oral Imatinib for Scleroderma Pulmonary Involvement
- Status
- UNKNOWN
- Phase
- PHASE2
Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic Sclerosis
- Status
- UNKNOWN
- Phase
- N/A
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
- Status
- COMPLETED
- Phase
- N/A
Rapamycin vs Methotrexate in Diffuse SSc
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-year Manometric Follow-up
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma
- Status
- COMPLETED
- Phase
- PHASE3
Scleroderma Registry
- Status
- COMPLETED
- Phase
- N/A
Stem Cell Transplant to Treat Patients With Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients
- Status
- TERMINATED
- Phase
- PHASE1
Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2